1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, July 2016 (p3)

Biological Therapy Analysis & Statistics, July 2016 (p3)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

61-90 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Critical Limb Ischemia Global Clinical Trials Review, H2, 2016

Critical Limb Ischemia Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Critical Limb Ischemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H2, 2016" provides an overview of Critical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Urinary Tract Cancer Global Clinical Trials Review, H2, 2016

Urinary Tract Cancer Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Urinary Tract Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Urinary Tract Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Urinary ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Papillary Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016

Papillary Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Papillary Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Papillary Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016" provides an ...

  • Industries : Cancer, Drug Discovery and Development, Pathology, Pharmaceutical
  • Countries : World
Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016

Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World
Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016

Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Renal Cell ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Ocular Melanoma Global Clinical Trials Review, H2, 2016

Ocular Melanoma Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Ocular Melanoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Ocular Melanoma Global Clinical Trials Review, H2, 2016" provides an overview of Ocular Melanoma clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, General Medicine and Specialty Medicine, Cancer, Biopharmaceutical, Pathology, Healthcare
  • Countries : World
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Cancer, Drug Discovery and Development, Pharmaceutical, Pathology
  • Countries : World
Non-Rhabdomyosarcoma Global Clinical Trials Review, H2, 2016

Non-Rhabdomyosarcoma Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Non-Rhabdomyosarcoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Non-Rhabdomyosarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Non-Rhabdomyosarcoma ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology, Therapy
  • Countries : World
Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World, United States
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Spinal Cord Injury Global Clinical Trials Review, H2, 2016

Spinal Cord Injury Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Spinal Cord Injury Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, H2, 2016" provides an overview of Spinal Cord ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Mental Health, Pathology
  • Countries : World
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016

Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Mental Health, Pathology, Biopharmaceutical
  • Countries : World
Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016

Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Multiple Sclerosis Global Clinical Trials Review, H2, 2016

Multiple Sclerosis Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Multiple Sclerosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Multiple Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Sclerosis ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Global Allergy Immunotherapies Market 2016-2020

Global Allergy Immunotherapies Market 2016-2020

  • $ 2 500
  • Industry report
  • July 2016
  • by Infiniti Research Limited

About the Allergy Immunotherapies Market Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such ...

  • Industries : Biological Therapy, Biotechnology, Chronic Disease
  • Countries : World, Europe
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, ...

  • Industries : Cancer, Pathology
  • Countries : United States
Melanoma - Pipeline Review, H1 2016

Melanoma - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Melanoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape. The report provides comprehensive ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Colorectal Cancer - Pipeline Review, H1 2016

Colorectal Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Colorectal Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape. The ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
HIV / AIDS - Pipeline Review, H1 2016

HIV / AIDS - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

HIV / AIDS - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2016’, provides an overview of the HIV / AIDS pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Healthcare, Biotechnology, Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : United States
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Malignant Mesothelioma Global Clinical Trials Review, H1, 2016

Malignant Mesothelioma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Malignant Mesothelioma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2016" provides an overview of Malignant ...

  • Industries : Drug Discovery and Development, Cancer, Pharmaceutical, Pathology
  • Countries : World
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : United States, World
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : United States, World
B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Neuroblastoma Global Clinical Trials Review, H1, 2016

Neuroblastoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Neuroblastoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroblastoma clinical ...

  • Industries : Cancer, Pharmaceutical, Drug Discovery and Development, Pathology, Therapy
  • Countries : World
Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Non-Small Cell Lung Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cance ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Prostate Cancer - Pipeline Review, H1 2016

Prostate Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape. The report ...

  • Industries : Cancer, Pathology
  • Countries : United States
Parkinson%s Disease - Pipeline Review, H1 2016

Parkinson%s Disease - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Parkinson's Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2016’, provides an overview of the Parkinson's Disease pipeline landscape. ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World
Ovarian Cancer - Pipeline Review, H1 2016

Ovarian Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape. The report provides ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Pancreatic Cancer - Pipeline Review, H1 2016

Pancreatic Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape. The ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.